What is the price target for CRH stock?
30 analysts have analysed CRH and the average price target is 141.99 USD. This implies a price increase of 34.12% is expected in the next year compared to the current price of 105.87.
NYSE:CRH • IE0001827041
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRH PLC (CRH).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-20 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-13 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-08 | UBS | Maintains | Buy -> Buy |
| 2026-01-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-16 | Longbow Research | Initiate | Buy |
| 2025-12-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-12 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-11-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-14 | UBS | Initiate | Buy |
| 2025-10-08 | Wells Fargo | Initiate | Overweight |
| 2025-10-02 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-26 | B of A Securities | Reiterate | Buy |
| 2025-09-11 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-10 | DA Davidson | Downgrade | Buy -> Neutral |
| 2025-04-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-09 | Loop Capital | Initiate | Buy |
| 2025-03-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.949B 6.80% | 35.572B 1.78% | 37.447B 5.27% | 40.107B 7.10% | 42.183B 5.18% | 45.129B 6.98% | 47.779B 5.87% | 51.823B 8.46% | |
| EBITDA YoY % growth | 6.12B 11.78% | 6.72B 9.80% | 7.479B 11.29% | 8.409B 12.43% | 9.011B 7.16% | 9.753B 8.23% | 10.014B 2.68% | 11.829B 18.12% | |
| EBIT YoY % growth | 4.487B 15.11% | 4.922B 9.69% | 5.323B 8.15% | 6.102B 14.63% | 6.638B 8.78% | 7.227B 8.87% | 7.848B 8.59% | 8.884B 13.20% | |
| Operating Margin | 12.84% | 13.84% | 14.21% | 15.21% | 15.74% | 16.01% | 16.43% | 17.14% | |
| EPS YoY % growth | N/A 16.89% | 4.76 5.09% | 5.57 17.02% | 6.09 9.41% | 6.87 12.68% | 7.63 11.15% | 8.00 4.80% | 8.86 10.73% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 5.79% | 2.13 8.67% | 2.45 10.76% | 1.56 3.04% | -0.27 -163.16% | 2.38 11.91% | 2.75 12.37% | 1.74 12.09% |
| Revenue Q2Q % growth | 7.155B 5.91% | 10.824B 6.06% | 11.765B 6.29% | 9.901B 5.15% | 7.34B 2.59% | 11.306B 4.45% | 12.395B 5.35% | 10.158B 2.60% |
| EBITDA Q2Q % growth | 654.95M 34.76% | 2.647B -9.38% | 2.908B -19.06% | 2.167B -39.25% | 511.57M -21.89% | 2.87B 8.42% | 3.192B 9.77% | 2.189B 1.02% |
| EBIT Q2Q % growth | 224.98M 2,399.78% | 2.066B 7.83% | 2.337B 17.61% | 1.515B 7.37% | -84.335M -137.49% | 2.269B 9.83% | 2.591B 10.87% | 1.588B 4.82% |
All data in USD
30 analysts have analysed CRH and the average price target is 141.99 USD. This implies a price increase of 34.12% is expected in the next year compared to the current price of 105.87.
CRH PLC (CRH) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of CRH PLC (CRH) is -0.1 USD and the consensus revenue estimate is 7.16B USD.
The consensus rating for CRH PLC (CRH) is 81.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.